These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 17435863

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Anabolic-androgenic steroid use among Brazilian bodybuilders.
    Nogueira FR, Brito Ade F, Oliveira CV, Vieira TI, Gouveia RL.
    Subst Use Misuse; 2014 Jul; 49(9):1138-45. PubMed ID: 24832911
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The anti-doping hot-line, a means to capture the abuse of doping agents in the Swedish society and a new service function in clinical pharmacology.
    Eklöf AC, Thurelius AM, Garle M, Rane A, Sjöqvist F.
    Eur J Clin Pharmacol; 2003 Nov; 59(8-9):571-7. PubMed ID: 13680032
    [Abstract] [Full Text] [Related]

  • 5. Stacking anabolic androgenic steroids (AAS) during puberty in rats: a neuroendocrine and behavioral assessment.
    Wesson DW, McGinnis MY.
    Pharmacol Biochem Behav; 2006 Mar; 83(3):410-9. PubMed ID: 16603236
    [Abstract] [Full Text] [Related]

  • 6. Prevalence of the use of anabolic-androgenic steroids in Brazil: a systematic review.
    Abrahin OS, Sousa EC, Santos AM.
    Subst Use Misuse; 2014 Jul; 49(9):1156-62. PubMed ID: 24766401
    [Abstract] [Full Text] [Related]

  • 7. Human growth hormone abuse in male weightlifters.
    Brennan BP, Kanayama G, Hudson JI, Pope HG.
    Am J Addict; 2011 Jul; 20(1):9-13. PubMed ID: 21175915
    [Abstract] [Full Text] [Related]

  • 8. Anabolic androgenic steroid-induced Takotsubo cardiomyopathy.
    Placci A, Sella G, Bellanti G, Margheri M.
    BMJ Case Rep; 2015 Mar 24; 2015():. PubMed ID: 25804946
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Nandrolone and stanozolol induce Leydig cell tumor proliferation through an estrogen-dependent mechanism involving IGF-I system.
    Chimento A, Sirianni R, Zolea F, De Luca A, Lanzino M, Catalano S, Andò S, Pezzi V.
    J Cell Physiol; 2012 May 24; 227(5):2079-88. PubMed ID: 21769864
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Rhabdomyolysis of the deltoid muscle in a bodybuilder using anabolic-androgenic steroids: a case report.
    Farkash U, Shabshin N, Pritsch Perry M.
    J Athl Train; 2009 May 24; 44(1):98-100. PubMed ID: 19180225
    [Abstract] [Full Text] [Related]

  • 15. Prevalence of anabolic steroid use and associated factors among body-builders in Hamadan, West province of Iran.
    Razavi Z, Moeini B, Shafiei Y, Bazmamoun H.
    J Res Health Sci; 2014 May 24; 14(2):163-6. PubMed ID: 24728754
    [Abstract] [Full Text] [Related]

  • 16. Anabolic ergogenic substance users in fitness-sports: a distinct group supported by the health care system.
    Striegel H, Simon P, Frisch S, Roecker K, Dietz K, Dickhuth HH, Ulrich R.
    Drug Alcohol Depend; 2006 Jan 04; 81(1):11-9. PubMed ID: 16009506
    [Abstract] [Full Text] [Related]

  • 17. Abuse of anabolic-androgenic steroids and bodybuilding acne: an underestimated health problem.
    Melnik B, Jansen T, Grabbe S.
    J Dtsch Dermatol Ges; 2007 Feb 04; 5(2):110-7. PubMed ID: 17274777
    [Abstract] [Full Text] [Related]

  • 18. Diagnosis and Management of Anabolic Androgenic Steroid Use.
    Anawalt BD.
    J Clin Endocrinol Metab; 2019 Jul 01; 104(7):2490-2500. PubMed ID: 30753550
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.